| Literature DB >> 35615944 |
Yaping Zhang1, Samuel M Ehrlich2, Cheng Zhu2,3, Xiaoping Du1.
Abstract
The glycoprotein Ib-IX (GPIb-IX) complex mediates initial platelet adhesion to von Willebrand factor (VWF) immobilized on subendothelial matrix and endothelial surfaces, and transmits VWF binding-induced signals to stimulate platelet activation. GPIb-IX also functions as part of a mechanosensor to convert mechanical force received via VWF binding into intracellular signals, thereby greatly enhancing platelet activation. Thrombin binding to GPIb-IX initiates GPIb-IX signaling cooperatively with protease-activated receptors to synergistically stimulate the platelet response to low-dose thrombin. GPIb-IX signaling may also occur following the binding of other GPIb-IX ligands such as leukocyte integrin αMβ2 and red cell-derived semaphorin 7A, contributing to thrombo-inflammation. GPIb-IX signaling requires the interaction between the cytoplasmic domains of GPIb-IX and 14-3-3 protein and is mediated through Src family kinases, the Rho family of small GTPases, phosphoinositide 3-kinase-Akt-cGMP-mitogen-activated protein kinase, and LIM kinase 1 signaling pathways, leading to calcium mobilization, integrin activation, and granule secretion. This review summarizes the current understanding of GPIb-IX signaling.Entities:
Keywords: Glycoprotein Ib (GPIb); integrin; intracellular signaling; platelet activation; thrombosis; von Willebrand factor
Mesh:
Substances:
Year: 2022 PMID: 35615944 PMCID: PMC9378482 DOI: 10.1080/09537104.2022.2071852
Source DB: PubMed Journal: Platelets ISSN: 0953-7104 Impact factor: 4.236